Skip to main content
. 2021 Apr 3;13(4):492. doi: 10.3390/pharmaceutics13040492

Figure 3.

Figure 3

Receptor-mediated transcytosis. The ligand engages with the receptor at the luminal side of the BBB, followed by receptor-mediated endocytosis of the receptor-ligand complex into the EC, forming a clathrin-coated vesicle. The vesicle fuses with the endosome, after which the vesicle undergoes exocytosis, and the biomolecule is released on the abluminal side of the BBB.